Director, Global Internal Controls
Akorn is a niche generic pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded pharmaceutical products in the areas of ophthalmology,retina, antidotes, anti-infectives, and controlled substances for pain management and anesthesia in the United States and across the globe.
SUMMARY Dedicated Audit Leader with over 12 years’ experience in operational and financial audits, SOX compliance, managerial and financial accounting. An effective and strategic professional with experience creating an Internal Audit function and reporting to the Audit Committee. Experienced in facilitating and implementing best practices that result in improvements to the control environment and the underlying business operations. Possess excellent verbal and written communication skills with strong analytical capabilities and the ability to adapt. Focused on continuous improvement and demonstrates unflinching ethics and integrity. REPRESENTATIVE ACHIEVEMENTS: •Built and executed the Company’s SOX framework within 5 months with one resource •Developed the Mergers and Acquisition Playbook for remediation of a Material Weakness •Conducted due diligence and post acquisition opening balance sheet reviews that identified $9million of errors •Saved over $500k in consulting costs by providing management with guidance on how to improve the financial close process. End result cut close time from 20 to 10 days •Drove improvements to inventory management practices releasing over $100 million tied up in working capital •Established a respected and progressive Internal Audit Department of 9 •Audit plan execution, presentation, and communication based on enterprise risk assessment and risk-based methodology